ライフサイエンスコーパス: cardiac disorder

1 rdiac events in patients with this inherited cardiac disorder.

2 y involved in an, as yet, unidentified human cardiac disorder.

3 age who have clinical evidence of a primary cardiac disorder.

4 trophic cardiomyopathy, and other hereditary cardiac disorders.

5 iple neurodegenerative disorders, aging, and cardiac disorders.

6 old hearts with implications for age-related cardiac disorders.

7 el a promising novel target for treatment of cardiac disorders.

8 tial of physical activity in obesity-related cardiac disorders.

9 otential of GPR55 as a therapeutic target in cardiac disorders.

10 mong the most frequently occurring inherited cardiac disorders.

11 ECM is observed in both pediatric and adult cardiac disorders.

12 new mechanisms in the pathogenesis of these cardiac disorders.

13 ariety of chronic neurologic, endocrine, and cardiac disorders.

14 on can be a potential therapeutic target for cardiac disorders.

15 y on subcellular scales and life-threatening cardiac disorders.

16 a role in the pathogenesis of lipid-related cardiac disorders.

17 ffer from a severe complication of different cardiac disorders.

18 as a valuable therapy for various end-stage cardiac disorders.

19 increase contractile force in patients with cardiac disorders.

20 t disease, accounting for 1-3% of congenital cardiac disorders.

21 derlie arrhythmias and sudden death in human cardiac disorders.

22 e apoptosis is potentially important in many cardiac disorders.

23 r than 1 month were excluded unless they had cardiac disorders.

24 3-4 adverse events of special interest were cardiac disorders (41 [8%] of 542 patients in the abirat

25 ebrile neutropenia (10% v 3%; P = .003), and cardiac disorders (5% v 5%; P = .759); transfusion rates

26 toxicity (188 [8%]), hypertension (99 [4%]), cardiac disorders (52 [2%]), osteoporosis (31 [1%]), hyp

27 ssion correlates with human diseases such as cardiac disorders and cancer.

28 Sera were obtained from 100 patients with cardiac disorders and periodontal disease and 73 patient

29 and duplications in 101 genes implicated in cardiac disorders and sudden death using a postmortem bl

30 ega-3 polyunsaturated fatty acids on various cardiac disorders and the risk factors for cardiac disea

31 brillation and heart failure are very common cardiac disorders, and both are associated with symptoms

32 ate cardiac function have been implicated in cardiac disorders, and efforts to develop therapeutic an

33 ividuals is commonly attributed to inherited cardiac disorders, and familial evaluation is advocated.

34 noic acid have beneficial effects in various cardiac disorders, and their use is recommended in guide

35 mostly hereditary, structural, or electrical cardiac disorders are associated with SCD in young athle

36 Concomitant chronic cardiac disorders are frequent in patients with COPD, li

37 Cardiac disorders are increasingly recognised as an impo

38 Cardiac disorders are the main cause of mortality in aut

39 ental gene associated with various important cardiac disorders, as a healthy adult cardiac fibroblast

40 luminated the genetic basis of the inherited cardiac disorders associated with sudden cardiac death.

41 da syndrome (BrS) is a highly arrhythmogenic cardiac disorder, associated with an increased incidence

42 Cardiac MRI (CMR) has been used for cardiac disorders, but its use in cryptogenic stroke is

43 ulators of inflammation and are activated in cardiac disorders, but their precise contributions and t

44 Long QT syndrome (LQT) is a cardiac disorder causing syncope and sudden death from a

45 icular cardiomyopathy (ARVC) is an inherited cardiac disorder characterized by loss of cardiomyocytes

46 with Wolff-Parkinson-White (WPW) syndrome, a cardiac disorder characterized by ventricular pre-excita

47 Cardiac disorders, coagulation abnormalities, and infect

48 This inherited cardiac disorder constitutes an important cause of malig

49 diomyopathy (HCM), the most common inherited cardiac disorder, exhibits remarkable genetic and clinic

50 y ), the most common genetically transmitted cardiac disorder, has been the focus of extensive resear

51 ysis of the CFC1 gene in patients with these cardiac disorders identified two disease-related mutatio

52 hereas the clinical course of this inherited cardiac disorder in the older population has not been st

53 arify the etiology of neurodevelopmental and cardiac disorders in children; however, the contribution

54 the hiPSC technology for modeling inherited cardiac disorders in general and ARVC specifically.

55 cular systolic dysfunction, a higher rate of cardiac disorders in the control groups than in the stud

56 The genetic bases of several cardiac disorders, including cardiomyopathies that cause

57 nies a wide spectrum of clinically important cardiac disorders, including ischemia/reperfusion, diabe

58 tress is common in many clinically important cardiac disorders, including ischemia/reperfusion, diabe

59 The onset of cardiac disorders indicated that subjects with truncatio

60 In the United Kingdom, screening for cardiac disorders is confined to symptomatic individuals

61 Adverse cardiac remodeling in RIHD and other cardiac disorders is frequently accompanied by mast cell

62 diomyopathy (HCM), the most common inherited cardiac disorder, is characterized by increased ventricu

63 rdiomyopathy (HCM) is a prevalent hereditary cardiac disorder linked to arrhythmia and sudden cardiac

64 Like the cardiac disorders (long QT syndrome type 3 or Brugada sy

65 icular cardiomyopathy (ARVC) is an inherited cardiac disorder mainly caused by dominant mutations in

66 re enriched in genes involved in metabolism, cardiac disorders, muscle contraction, reproduction, beh

67 (12% belatacept versus 8% CsA), and serious cardiac disorders occurred more frequently with CsA (2%

68 n of Na(+) channels and Na(+) homeostasis in cardiac disorders of excitability and mechanics emphasiz

69 e in this homeostasis is likely to influence cardiac disorders or cardiomyopathy.

70 tio, 2.2; 95% CI, 1.6-3.1) versus those with cardiac disorders (subhazard ratio, 1.5; 95% CI, 0.9-2.5

71 s such as Alzheimer disease and epilepsy and cardiac disorders such as coronary artery disease and my

72 he development of optogenetic treatments for cardiac disorders such as the long QT syndrome.

73 Long-QT (LQT) syndrome is a cardiac disorder that causes syncope, seizures, and sudd

74 ms underlying long QT syndrome, an inherited cardiac disorder that causes syncope, seizures, and sudd

75 Long QT syndrome (LQT) is an inherited cardiac disorder that results in syncope, seizures, and

76 emic cardiomyopathies are a diverse group of cardiac disorders that frequently cause heart failure an

77 es account for more than 50% of an inherited cardiac disorder, the Long QT syndrome.

78 By serving as models of inherited cardiac disorders, these systems have the potential to f

79 C-CMs) from patients with various hereditary cardiac disorders to model differences in cardiac drug t

80 of discontinuation of trastuzumab because of cardiac disorders was low (5.1%).

81 Neonates with possible cardiac disorders were identified by the general pediatr

82 77 LMNA mutation carriers from 45 families; cardiac disorders were retrospectively analyzed.

83 people with chronic morbidity; diabetes and cardiac disorders were the main susceptibility factors.

84 ent adverse events, including infections and cardiac disorders, were similar in the amiselimod treatm

85 ssible therapeutic potential of rapamycin in cardiac disorders where pathologic mTORC1 activation occ

86 her mutations that may underlie many genetic cardiac disorders, whereas RNA sequencing can be used to

87 r data suggest a novel pathogenic process in cardiac disorders with abnormal protein aggregation.

88 an important pathogenic mechanism underlying cardiac disorders with abnormal protein aggregation.

89 he significance of sudden death in heritable cardiac disorders with delayed expression is incompletel

90 ces the clinical management and treatment of cardiac disorders with highly variable outcome.

91 omyopathy (HCM) is the most common inherited cardiac disorder, with an overall prevalence of at least